Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion (NCT01724554)Ophthalmic Consultants of Boston2012-11-01
ALLPS VERSUS PVO Randomized Controlled Trial (NCT01775267)University of Zurich2012-11-01
Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets (NCT02353429)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2012-11-01
Outpatient Pump Shutoff Pilot Feasibility and Efficacy Study (NCT01591681)Jaeb Center for Health Research2012-11-01
Prevention of Post-Traumatic Stress Disorder in Soldiers (NCT01729325)University of Konstanz2012-11-01
An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough (NCT01703923)Avalo Therapeutics, Inc.2012-11-01
Methylprednisolone N Acetylcysteine in Hepatic Resections (NCT01726465)Istituto Clinico Humanitas2012-11-01
Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients (NCT01528800)Dr. Rachel Holden2012-11-01
Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis (NCT01744444)Hospices Civils de Lyon2012-11-01
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer (NCT01720836)Olivera Finn2012-11-01
Effect of Antenatal Corticosteroids in Late Preterm (NCT01710384)Meir Medical Center2012-11-01
Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma (NCT01812018)Peng Yuan2012-11-01
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex (NCT01730209)Erasmus Medical Center2012-11-01
Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy (NCT01644097)Stanford University2012-11-01
Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes (NCT01690091)Institute for Clinical and Experimental Medicine2012-11-01
Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis (NCT01748344)Ono Pharmaceutical Co., Ltd.2012-11-01
Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure (NCT01731002)Aerie Pharmaceuticals2012-11-01
Evaluation of the Modified Atkins Diet in Young Children With Refractory Epilepsy (NCT01880333)Lady Hardinge Medical College2012-11-01
Treatment of PTSD by Reduction of Traumatic Memory Reconsolidation by Propranolol : a Multisite Trial (NCT01713556)University Hospital, Toulouse2012-11-01
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma (NCT01668719)SWOG Cancer Research Network2012-11-01
Biological Standardization of Platanus Acerifolia Allergen Extract (NCT01739322)Laboratorios Leti, S.L.2012-11-01
Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant (NCT01666951)Veloxis Pharmaceuticals2012-11-01
Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital (NCT01766011)Abbott Nutrition2012-11-01
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT01707381)Bausch & Lomb Incorporated2012-11-01
Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) (NCT01950936)Danish Procalcitonin Study Group2012-11-01
Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults (NCT01737892)Amphastar Pharmaceuticals, Inc.2012-11-01
Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants (NCT01684163)Naurex, Inc, an affiliate of Allergan plc2012-11-01
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer (NCT01700010)University of Michigan Rogel Cancer Center2012-11-01
Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas (NCT01730586)M.D. Anderson Cancer Center2012-11-01
Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) (NCT01718964)Prof. Dominique de Quervain, MD2012-11-01
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis (NCT01736397)Keryx Biopharmaceuticals2012-11-01
A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (NCT01697007)Muhimbili University of Health and Allied Sciences2012-11-01
Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure (NCT01724398)Third Affiliated Hospital, Sun Yat-Sen University2012-11-01
Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting (NCT01429012)University of Liege2012-11-01
REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) (NCT01875081)Pharmicell Co., Ltd.2012-11-01
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus (NCT01673191)Retinal Consultants of Arizona2012-11-01
Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease (NCT01925352)The First Affiliated Hospital with Nanjing Medical University2012-11-01
Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea (NCT01754285)Chemi S.p.A.2012-11-01
A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C (NCT01726946)Vertex Pharmaceuticals Incorporated2012-11-01
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes (NCT01666028)University of Cambridge2012-11-01
Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function (NCT01734200)Chonbuk National University Hospital2012-11-01
Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa (NCT01642550)Motus Therapeutics, Inc.2012-11-01
Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT01733238)Sierra Oncology LLC - a GSK company2012-11-01
Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza (NCT01740063)Ansun Biopharma, Inc.2012-11-01
Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (NCT01723982)Ferring Pharmaceuticals2012-11-01
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma (NCT01703312)Novartis Pharmaceuticals2012-11-01
Reinforcement of Closure of Stoma Site (NCT02238964)University of Birmingham2012-11-01
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma (NCT01739465)Guangzhou Medical University2012-11-01
Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS) (NCT01739855)Medical University of Vienna2012-11-01
Biological Potency of the Cat Epithelial Allergenic Extracts (NCT01740024)Laboratorios Leti, S.L.2012-11-01
Ganaxolone Treatment in Children With Fragile X Syndrome (NCT01725152)Marinus Pharmaceuticals2012-11-01
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma. (NCT01704495)AstraZeneca2012-11-01
Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis (NCT01786057)Isfahan University of Medical Sciences2012-11-01
BIOHELIX-I Bare Metal Stent Study (NCT01612767)Biotronik, Inc.2012-11-01
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01648348)National Cancer Institute (NCI)2012-11-01
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery (NCT01612546)City of Hope Medical Center2012-11-01
Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome (NCT01721733)PTC Therapeutics2012-10-31
Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) (NCT01731210)LivaNova2012-10-31
A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate (NCT01679951)Janssen Research & Development, LLC2012-10-31
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT01666444)Celgene2012-10-31
An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (NCT01703988)Biogen2012-10-31
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) (NCT01716806)Seagen Inc.2012-10-31
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer (NCT01658878)Bristol-Myers Squibb2012-10-30
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate (NCT01636843)Novo Nordisk A/S2012-10-30
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease (NCT01731990)Novartis Pharmaceuticals2012-10-30
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes (NCT01687595)Agenus Inc.2012-10-29
Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis (NCT01731951)Geron Corporation2012-10-29
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas (NCT01595321)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2012-10-29
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH (NCT01672879)Gilead Sciences2012-10-29
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies (NCT01664910)M.D. Anderson Cancer Center2012-10-29
Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer (NCT01622543)Canadian Cancer Trials Group2012-10-26
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies (NCT01745913)Weill Medical College of Cornell University2012-10-26
Ruxolitinib for Adult T-Cell Leukemia (NCT01712659)National Cancer Institute (NCI)2012-10-26
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma (NCT01701986)M.D. Anderson Cancer Center2012-10-25
GDNF in ideopathicParkinsons Disease (NCT03652363)North Bristol NHS Trust2012-10-25
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) (NCT01392183)M.D. Anderson Cancer Center2012-10-24
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy (NCT01677754)Hoffmann-La Roche2012-10-24
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer (NCT01711541)National Cancer Institute (NCI)2012-10-22
Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia (NCT01769274)Pfizer2012-10-22
Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer (NCT01657799)AbbVie (prior sponsor, Abbott)2012-10-19
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer (NCT01684215)Pfizer2012-10-19
Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF) (NCT01759511)Gilead Sciences2012-10-18
Vision Response to Dopamine Replacement (NCT01663935)University of Wisconsin, Madison2012-10-17
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism (NCT01673646)Novartis Pharmaceuticals2012-10-16
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation (NCT01810588)Weill Medical College of Cornell University2012-10-16
MSCs For Treatment of Azoospermic Patients (NCT02025270)Al-Azhar University2012-10-15
A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients (NCT01649388)Talaris Therapeutics Inc.2012-10-15
A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007) (NCT01632345)Merck Sharp & Dohme LLC2012-10-12
NeSST2: The Development of a Noninvasive Short Synacthen Test (NCT03514589)Sheffield Children's NHS Foundation Trust2012-10-12
Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis (NCT01992159)Amgen2012-10-12
A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (NCT01559363)Kadmon, a Sanofi Company2012-10-11
Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. (NCT01687192)University Hospital, Bordeaux2012-10-11
Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma (NCT01794520)AbbVie2012-10-10
Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. (NCT01571635)Celgene2012-10-10
Phase I/II Study of DFP-10917 in Patients With Acute Leukemia (NCT01702155)Delta-Fly Pharma, Inc.2012-10-10
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (NCT01654263)National Institute of Allergy and Infectious Diseases (NIAID)2012-10-10
Local Treatment by Thermic Destruction of Primitive Breast Cancer (NCT01706016)Gustave Roussy, Cancer Campus, Grand Paris2012-10-09
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy (NCT01679197)University of Michigan2012-10-08
A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors (NCT01714739)Bristol-Myers Squibb2012-10-07
Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (NCT01712646)National Institute of Mental Health (NIMH)2012-10-05
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.